# Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL

> **NCT03792633** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 106 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **BIOLOGICAL:** huCART19

## Key facts

- **NCT ID:** NCT03792633
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-18
- **Primary completion:** 2024-04-04
- **Final completion:** 2024-04-04
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792633, "Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03792633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*